Community Funding Opportunities

Fragile Families Challenge

Due Date: 08-01-2017
What would happen if hundreds of social scientists and data scientists worked together on a scientific challenge to improve the lives of disadvantaged children in the U.S.? The Fragile Families Challenge is a mass collaboration that will combine predictive modeling, causal inference, and in-depth interviews to yield insights that can improve the lives of disadvantaged children in the U.S.

Health Services Research on Minority Health & Health Disparities (R21)

Due Date: 01-09-2017
The purpose of this FOA is to encourage innovative exploratory and developmental health services research to improve minority health and/or reduce health disparities at the health care system-level as well as within clinical settings. R01 also available

Buffett Family Foundation Pledged $90 Million to Aid Young Women of Color

The money will be deployed by the NoVo Foundation via three streams to fund: 1) community-based organizations¿ budget line items on continuing operations; 2) organizations and efforts in the southeastern U.S. in concert with a yet-undetermined regional partner. This money will also be used to form new organizations necessary to affect change and to fund individual efforts that may exist outside of established organizations; 3) broader concerns on a national level, including research organizations and policy change measures.

Breast Health Outreach Grants

The Avon Breast Health Outreach Program (BHOP) provides grants to nonprofit organizations to conduct outreach, provide education on breast health and breast cancer screening, link medically underserved women to care providers and clinical screening services, and help navigate patients through any necessary follow-up care.

Empowered Communities for a Healthier Nation Initiative

Due Date: 08-01-2017
HHS Office of Minority Health announces the anticipated availability of funds for cooperative agreement grant awards for the Empowered Communities for a Healthier Nation Initiative. The program is intended to provide support for minority and/or disadvantaged communities disproportionately impacted by the opioid epidemic, childhood/adolescent obesity, or serious mental illness. It seeks to prevent opioid abuse, increase access to opioid treatment and recovery services, and reduce the health consequences of opioid abuse; reduce obesity prevalence and disparities in weight status among children and adolescents; and reduce the impact of serious mental illness and improve screening for serious mental illness at the primary care level.

Discovery Funding Opportunities

Strategic Research Agreements

Due Date: 08-01-2017
JDRF¿s agreements provide research funding for single or multiple investigators to address critical gaps and challenges and potential breakthroughs in Type 1 diabetes research. The Strategic Research Agreement is a partnership between Investigator(s) and JDRF Scientists to help address roadblocks and accelerate JDRF¿s mission through support of cutting-edge scientific investigation.

Mechanistic Ancillary Studies to Ongoing Interventional Clinical Trials (R01)

Due Date: 08-07-2017
This FOA solicits applications that propose to conduct time-sensitive mechanistic ancillary studies related to the NIAMS mission in conjunction with privately or publicly funded, ongoing interventional clinical trials. The ongoing ¿parent¿ project has to be an interventional clinical trial that can provide a cohort of well-characterized patients, infrastructure, data, and biological samples. R21 also available

Pediatric Early Phase Clinical Trials Network (UM1)

Due Date: 08-16-2017
The purpose of this FOA is to enhance NCI¿s program for conducting early phase clinical trials in children with cancer, currently supported as the Children's Oncology Group (COG) Phase 1 & Pilot Consortium. The overall goal is to ensure that high priority novel agents can be tested in pediatric patients in a timely manner.

Spinal Cord Injury (SCI) Research Program Translational Research Award

Due Date: 08-08-2017
The program encourages applications that specifically address pre-hospital, prolonged field care, en route care, and early hospital management of SCI; development, validation, and timing of promising interventions to address consequences of SCI and to improve recovery; and Identification and validation of best practices in SCI care throughout the lifetime of the individual. Investigator-initiated award also available.

Tobacco Regulatory Science (R01)

Due Date: 08-17-2017
The purpose of this FOA is to invite R01 applications to support biomedical and behavioral research that will provide scientific data to inform regulation of tobacco products to protect public health.

Translational Outcomes Project in Neurotrauma (TOP-NT) (UG3/UH3)

Due Date: 08-21-2017
The purpose of this FOA is to support the development and validation of pathophysiologically-based preclinical outcome measures or functional markers that align closely with practical clinical assessments in spinal cord injury and/or traumatic brain injury. Bedside knowledge and experience will be leveraged to create better assessment tools for preclinical studies, and the resulting data will be made available to researchers. The goal is to improve the value of preclinical studies to inform clinical diagnoses and prognoses and therapeutic translation.

UGA Clinical & Translational Research Unit (CTRU) Seed Grant Funding Announcement -Due August 21

Due Date: 08-21-2017

The CTRU announces an opportunity for FY18 funding (up to $40,000) to support pilot studies based in the University of Georgia CTRU.

Global Pediatric Clinical Trials Network (U18)

Due Date: 08-22-2017
The goals of this program are to support the development of the scientific infrastructure needed to plan and execute pediatric clinical trials through collaboration with stakeholders from academia, industry, parent/patient advocacy groups, and government agencies.

NIH Director¿s Pioneer Award Program (DP1)

Due Date: 09-01-2017
The award complements NIH's traditional, investigator-initiated grant programs by supporting individual scientists of exceptional creativity who propose pioneering and possibly transforming approaches to addressing major biomedical or behavioral challenges that have the potential to produce an unusually high impact on enhancing health, lengthening life, and reducing illness and disability.

Georgia Center for Diabetes Translation Research Small Grant Awards (GCDTR-03)

Due Date: 09-05-2017
Emory University, in partnership with the Georgia Tech and the Morehouse School of Medicine, recently received funding from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to establish the Georgia Center for Diabetes Translation Research (Georgia CDTR). This Request for Pilot and Feasibility Applications is a solicitation for pilot proposals that focus on Type II translation research in diabetes care and prevention.

Transatlantic Networks of Excellence in Cardiovascular & Neurovascular Research Program

Due Date: 09-05-2017
Fondation Leducq is a private charitable foundation, based in Paris, France, dedicated to improving human health through international efforts to combat cardiovascular and neurovascular disease. In support of this mission the Fondation Leducq has created the Transatlantic Networks of Excellence in Cardiovascular and Neurovascular Research Program, which promotes internationally collaborative basic, translational, and clinical research in cardiovascular and neurovascular disease.

Stand Up To Cancer Dream Team Translational Research Grant

Due Date: 09-05-2017
The Stand Up To Cancer Dream Team Translational Research Grant represents a new, focused effort to implement advances in cancer research as rapidly as possible through the creation of a collaborative, translational, cancer research "Dream Team." The most talented and promising researchers across institutions will be assembled into a Dream Team, forming an optimal configuration of expertise needed to solve key problems in cancer and positively impact patients in the near future.

Concern Foundation¿s Conquer Cancer Now Award

Due Date: 09-07-2017
Proposals must be hypothesis-driven and centered on cancer genetics, cancer biology, or cancer immunology. Concern will not fund clinical trials, cancer epidemiology, or behavioral studies.

NIH Director's New Innovator Award Program (DP2)

Due Date: 09-15-2017
The NIH Director's New Innovator Award addresses two important goals: stimulating highly innovative research and supporting promising new investigators. New investigators may have exceptionally innovative research ideas, but not the preliminary data required to fare well in the traditional NIH peer review system.

Developing New Clinical Decision Support (CDS) to Disseminate & Implement Evidence-Based Research Findings (R18)

Due Date: 09-15-2017
The purposes of this FOA are to develop new, reliable, valid, and usable CDS from evidence-based research findings and then demonstrate its effectiveness to improve care in clinical practice.

The Andrew McDonough B+ Foundation Childhood Cancer Research Grant

Due Date: 09-15-2017
The foundation funds cutting-edge childhood cancer research. The B+ Foundation funds grants that support basic, translational or clinical research, which may lead towards cures and better treatments for childhood cancers.

NIH Director's Transformative Research Awards (R01)

Due Date: 09-15-2017
The goal of the award is to provide support for collaborative investigative teams or individual scientists who propose unusually innovative research projects, which, if successful, would have a major impact in a broad area of biomedical or behavioral research. To be considered transformative, projects must have the potential to create or overturn fundamental scientific paradigms through the use of novel approaches, to transform the way research is conducted through the development of novel tools or technologies, or to lead to major improvements in health through the development of highly innovative therapies, diagnostic tools, or preventive strategies.

LAM Foundation: Pilot & Feasibility Grant

Due Date: 09-15-2017
Proposed work must be hypothesis generating or hypothesis testing, reflecting innovative approaches to important questions in LAM research or development of novel methods, and providing sufficient preliminary data to justify support.

Scleroderma Foundation Established Investigator Grant

Due Date: 09-15-2017
The foundation seeks applications from promising established investigators both inside and outside the field of scleroderma research who wish to propose pilot studies to obtain preliminary data dealing with a highly innovative and/or highly relevant theme related to the disease. New Investigator Grant also available.

NIDCD Research Grants for Translating Basic Research into Clinical Tools (R01) PAR-17-184

Due Date: 09-18-2017
This funding opportunity seeks teams comprising basic and clinical researchers and clinicians to develop tools for improved diagnosis, treatment, and prevention of hearing, balance, smell, taste, voice, speech, or language disorders.

Thrasher Research Fund Invites Concept Papers for Early-Career Grants

Due Date: 09-19-2017
The fund provides grants for clinical, hypothesis-driven research that offers substantial promise for meaningful advances in the prevention, diagnosis, and treatment of children's diseases, particularly research that offers broad-based applications.

2017-2018 American Thoracic Society (ATS) Foundation Unrestricted Grants

Due Date: 09-19-2017
The focus of these grants is to support early career investigators interested in research that advances the knowledge and understanding of the ATS's three pillars: pulmonary, critical care, and sleep medicine.

Socioeconomic Disparities in Health & Mortality at Older Ages (R01)

Due Date: 09-20-2017
The purpose of this FOA is to support studies that identify mechanisms, explanations, and modifiable risk factors underlying recent trends of growing inequalities in morbidity and mortality by income, education, and geographic location at older ages in the U.S.

NIH Director's Early Independence Awards (DP5)

Due Date: 09-22-2017
The program supports exceptional investigators who wish to pursue independent research directly after completion of their terminal doctoral/research degree or clinical residency, thereby forgoing the traditional post-doctoral training period and accelerating their entry into an independent research career.

Biomedical Technology Research Resource (P41)

Due Date: 09-25-2017
This FOA encourages grant applications for national Biomedical Technology Research Resources (BTRR). These resources conduct research and development of new or improved technologies driven by the needs of basic, translational, and clinical researchers. The resources are charged to make their technologies available to the research community in a sustainable manner, to provide user training, and to disseminate the resource's technologies and experimental results.

Chicago Community Trust Searle Scholars Program

Due Date: 09-29-2017
The program is intended to support research in medicine, chemistry, and the biological science. To achieve this goal, grants will be made to selected academic institutions to support the independent research of outstanding individuals who are in the first or second year of their first appointment at the assistant professor level, and whose current appointment is a tenure-track position.

NIDDK: George M. O'Brien Kidney Research Core Centers (P30)

Due Date: 10-01-2017
The goal of the O'Brien Kidney Research Center program is to make state-of-the art technologies and resources readily accessible to a broad spectrum of investigators pursuing studies in relevant topic areas.

Whitehall Foundation Research Grants

Due Date: 10-01-2017
It is the foundation's policy to assist those dynamic areas of basic biological research that are not heavily supported by federal agencies or other foundations with specialized missions. The foundation is currently interested in basic research in neurobiology and emphasizes the support of young scientists at the beginning of their careers and productive senior scientists who wish to move into new fields of interest.

Sartorius & Science Prize for Regenerative Medicine & Cell Therapy

Due Date: 10-01-2017
The annual prize is geared towards researchers focused on basic or translational research that advances regenerative medicine and cell therapy. Entries can be made in the fields of regenerative medicine, cell therapy, gene therapy, immunotherapy as well as materials and tissue engineering.

Major Research Instrumentation Program: (MRI) Instrument Acquisition or Development

Due Date: 10-02-2017
The program intends to fund the development or acquisition of major state-of-the-art instrumentation for research or research training in any NSF-supported field.

NIAMS Rheumatic Diseases Research Resource-based Centers (P30)

Due Date: 10-03-2017
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) requests applications for for rheumatic diseases research areas within its mission. The Resource-based Centers will provide critical research infrastructure, shared facilities, services, and/or resources to groups of investigators conducting research on rheumatic diseases, enabling them to conduct their independently-funded individual and/or collaborative research projects more efficiently and/or more effectively, with the broad overall goal of accelerating, enriching, and enhancing the effectiveness of ongoing basic, translational, and clinical research and promoting new research.

NIGMS Maximizing Investigators¿ Research Award (MIRA) Program for Early Stage Investigators (ESIs)

Due Date: 10-03-2017
A FAQ on the FOA is available

Partnerships for Development of Clinically Useful Diagnostics for Antimicrobial-Resistant Bacteria (R01)

Due Date: 10-04-2017
The objective of this initiative is to support milestone-driven projects focused on the development of clinically informative diagnostic platforms that identify select antimicrobial-resistant bacterial pathogens and determine associated antimicrobial sensitivity and/or resistance.

Extramural Loan Repayment Program

Due Date: 10-15-2017
The Clinical Researchers and Health Disparities Research programs were established by Congress and designed to recruit and retain highly qualified health professionals into biomedical or biobehavioral research careers.

NICHD Exploratory/Developmental Research Grant (R21)

Due Date: 10-16-2017
These studies may involve considerable risk but may lead to a breakthrough in a particular area, or to the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of biomedical, behavioral, or clinical research.

Catalyzing Innovation in Late Phase Clinical Trial Design & Statistical Analysis Plans (U34)-Due October 19

Due Date: 10-19-2017
The purpose of this FOA is to provide support for planning activities for late phase (phase II and beyond) single-site or multi-site investigator-initiated clinical trials that address critical clinical questions within the mission of the National Heart, Lung, and Blood Institute (NHLBI) and that require non-traditional clinical trial designs with the opportunity for statistical novelty and/or innovation. An X01 is also available

Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MRSRCs) (P50)

Due Date: 10-19-2017
These centers promote collaborative basic, translational and clinical research and provide important resources that can be used by the national muscular dystrophy research communities.

Increasing Use of Cardiac & Pulmonary Rehabilitation in Traditional & Community Settings (R61/R33)

Due Date: 10-19-2017
The purpose of this initiative is to support Phase 2 clinical trials to develop and test strategies to increase the utilization of cardiovascular rehabilitation (CR) and pulmonary rehabilitation (PR) in eligible patients.

Pragmatic Research in Healthcare Settings to improve Kidney Disease Prevention & Care (R18)

Due Date: 10-24-2017
The purpose of this FOA is to encourage research applications to test approaches to improve kidney disease prevention and/or treatment in routine healthcare settings. Research applications should be designed to test practical and potentially sustainable strategies that target the prevention or improved care of kidney disease, or the prevention or delay of the complications of kidney disease. The goal of the research is to obtain results that will improve routine healthcare practice and inform healthcare policy for the prevention or management of these conditions.

Centers of Excellence in Ethical, Legal, & Social Implications Research (CEER) (RM1)

Due Date: 10-31-2017
The CEER program is designed to support the establishment of sustainable trans-disciplinary research teams with the expertise and flexibility to anticipate, conduct research on, and quickly address a range of cutting edge ethical, legal, and social issues related to genetics and genomics.

Preparing for Hybrid Effectiveness-Implementation Trials for Heart, Lung, Blood, & Sleep Diseases in the Inpatient Setting (U01)

Due Date: 10-31-2017
The purpose of this Funding Opportunity Announcement (FOA) is to support investigators performing research to identify the barriers and facilitators to implementation of an evidence-based practice(s) for heart, lung, blood, and sleep (HLBS) diseases in the inpatient setting. NHLBI is seeking applications that will utilize an implementation research framework to develop an implementation strategy (or strategies) to be tested during a subsequent hybrid effectiveness-implementation trial.

Center for Identification & Study of Individuals with Atypical Diabetes Mellitus (U54)

Due Date: 11-02-2017
The purpose of this center is to: foster the study of individuals with rare/atypical forms of diabetes mellitus; identify and analyze phenotypic and genotypic defects that may provide insights into more common, heterogeneous forms of Type 2 diabetes mellitus (T2DM) in the general population; and develop a community resource to advance research in this area through the collection and dissemination of data and samples for access by the broad research community.

Mobile Monitoring of Cognitive Change (U2C)

Due Date: 11-02-2017
This FOA invites applications to design and implement research infrastructure that will enable the monitoring of cognitive abilities and age, state, context, or health condition-related changes in cognitive abilities on mobile devices.

Gerber Foundation Seeks Proposals for Pediatric Research Projects

Due Date: 12-01-2017
The Gerber Foundation is accepting concept papers for health and/or nutrition-related research projects with the potential to have a significant impact on issues facing infants and young children from birth to three years of age.

Biomarkers: Bridging Pediatric & Adult Therapeutics (R21)

This FOA encourages grant applications that propose adapting adult biomarkers to children. This would include the application and validation of biomarkers developed in adults to pediatric diagnosis, prognosis, and estimation of disease progression, toxicity, and response to therapy.

NIH Commons Credits Model

The NIH Commons Credits Model is a time- and cost-efficient way for NIH-funded biomedical investigators to gain cloud computing support for their current research as well as pave the way toward better accessibility, interoperability, and reuse of digital objects for future research. This is not a grant; this funding is recommended to supplement current NIH grants or to jump start a related grant in the biomedical space.

Advancing the Science of Geriatric Palliative Care (R01 & R21)

This FOA encourages exploratory or developmental research grant applications to develop new tools, methods, and models focused on palliative care in geriatric populations. The request for applications covers studies in a variety of healthcare or community settings. R01 and R21 available

RJWF Evidence for Action: Investigator-Initiated Research to Build a Culture of Health

Evidence for Action (E4A), a national program of the Robert Wood Johnson Foundation, funds research that expands the evidence base needed to build a Culture of Health. Their mission is to support rigorously designed quantitative, qualitative, and mixed methods research that yields convincing findings regarding the population health, well-being, and equity impacts of specific policies, programs and partnerships.

Ethical, Legal, & Social Implications (ELSI) of Genomics Research Project Grant Program (R01)

This FOA invites R01 applications that propose to study the ethical, legal and social implications (ELSI) of human genome research. Proposed approaches may include but are not limited to data-generating qualitative and quantitative approaches, legal, economic and normative analyses, and other types of analytical and conceptual research methodologies, such as those involving the direct engagement of stakeholders.

Small Grants for Secondary Analyses of Existing Data Sets & Stored Biospecimens (R03)

This FOA encourages applications that propose to conduct secondary analyses of publicly available NICHD-funded data sets or stored biospecimens. The goal of this program is to facilitate innovative yet cost-effective research utilizing data and biospecimens collected with NICHD resources.

NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules (X02 and UG3/UH3)

The program is designed to develop partnerships between pharmaceutical companies and the biomedical research community to advance therapeutics development. X02, UG3/UH3, and pediatric UG3/UH3 available.

Quick Wins

Are you frustrated with a device that you use? Is there a clinical process you see that needs improvement? Do you have a brilliant idea for a system, device, or program that would make life better `For the Kids¿? Quick Wins is a funding program put in place to provide rapid solutions to unmet clinical and business needs at Children¿s Healthcare of Atlanta.

Training Funding Opportunities

Career Development Bridge Funding Award: K Supplement

Due Date: 08-01-2017
The awards are designed to encourage early and mid-career investigators to continue vital research into the cause, prevention, and treatment of rheumatic diseases. The purpose of this award is to encourage junior investigators to expand promising research by providing additional support to cover research costs and help investigators become independent.

Beckman Foundation Accepting LOIs for Young Investigator Program-

Due Date: 08-14-2017
The annual program is intended to provide research support to the most promising young faculty members in the early stages of academic careers in the chemical and life sciences particularly to foster the invention of methods, instruments, and materials that will open up new avenues of research in science.

Lasker/NIH Clinical Research Scholars

Due Date: 08-25-2017
This is a competitive opportunity for early-stage physician-scientists to conduct independent clinical and translational research as tenure-track investigators at the NIH and in academia. It was established to create career research opportunities for physician-scientists (it also includes dental and nurse scientists) and is targeted to outstanding post-fellowship physicians and other clinicians with strong research interests and credentials.

NIH Director's Early Independence Awards (DP5)

Due Date: 09-22-2017
The program supports exceptional investigators who wish to pursue independent research directly after completion of their terminal doctoral/research degree or clinical residency, thereby forgoing the traditional post-doctoral training period and accelerating their entry into an independent research career.

NIH National Institute of General Medical Sciences (NIGMS) Bridges to the Doctorate (R25)

Due Date: 09-25-2017
The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NIGMS R25 program is to support educational activities that enhance the diversity of the biomedical research workforce. To accomplish this goal, the FOA will support creative educational activities with a primary focus on Courses for Skills Development and Research Experiences.

Reproductive Scientist Development Program (RSDP) (K12)

Due Date: 09-30-2017
This program constitutes a national network of mentors and scholars, in contrast to K12 programs that are based solely at a single applicant institution.

Burroughs Wellcome Fund: Career Awards for Medical Scientists

Due Date: 10-03-2017
The award is a highly competitive program that provides $700,000 awards over five years for physician-scientists, who are committed to an academic career, to bridge advanced postdoctoral/fellowship training and the early years of faculty service.

Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76)

Due Date: 10-19-2017
This FOA invites early-stage physician and other health-professional investigators with a commitment to aging to apply for this award to advance their research and leadership skills in their specialty and in the broader field of aging and geriatrics research. The National Institute on Aging is pursuing this initiative to recruit new investigators who have begun to establish research programs and who, through this award, will be ready to assume leadership roles in their field of expertise and will be poised to change theory, practice and health outcomes related to the health of older individuals.

Pew Charitable Trusts: Pew Scholars Program in the Biomedical Sciences

Due Date: 10-23-2017
The program is intended to support young investigators of outstanding promise in science relevant to the advancement of human health. The program makes grants to selected academic institutions to support the independent research of outstanding individuals who are in their first few years of their appointment at the assistant professor level.

Call For Applicants: Jefferson Science Fellowship Program

Due Date: 10-31-2017
The National Academies of Sciences, Engineering, and Medicine is pleased to announce a call for applications for the 2018 Jefferson Science Fellowship program. The fellowship is open to tenured, or similarly ranked, academic scientists, engineers, and physicians from U.S. institutions of higher learning.

Commercialization Funding Opportunities

Atlantic Pediatric Device Consortium 7th Annual Pediatric Device Innovation Competition

Due Date: 07-31-2017
This seed grant competition is an opportunity for the scientific and business community including entrepreneurs, clinicians, scientists, businesses, academic researchers and medical and engineering graduate and undergraduate students, to develop and commercialize a pediatric medical device. The proposal should be directed towards development of a commercializable product, not research of a scientific concept.

What Tech Startups Are Coke Worthy?

With a 4% Atlanta-based soft drink giant, Coca-Cola, just announced The Bridge, a six-month commercialization program to develop early-stage partnerships.

Wearable to Track Recovery & Relapse Factors for People with Addiction (R43/R44)

Due Date: 08-15-2017
The purpose of this FOA is to encourage small businesses (SBCs) to develop next generation wearables and supporting mobile applications to identify digital biomarkers associated with reinitiating drug use and relapse, and create a model for just-in-time intervention.

Nasal Delivery of CNS Therapeutics (R43/R44)

Due Date: 08-23-2017
The purpose of this Small Business Technology Transfer (STTR) RFA is to develop a nasal delivery formulation that reliably delivers of a therapeutic (e.g., peptides, antibodies, RNAi, or pharmacotherapeutics), at a physiologically relevant concentration, into the central nervous system (CNS). R41/R42 also available.

NCATS SBIR/STTR Funding Opportunities

Due Date: 09-05-2017
NCATS has several open Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) program funding opportunities. SBIR and STTR funding supports small businesses working on the advancement and commercialization of translational research technologies. NCATS encourages applications in drug discovery and development; biomedical, clinical and health research informatics; clinical, dissemination and implementation research; and clinical trials.

Upcoming Events

View All Events

Funding News


UGA Clinical & Translational Research Unit (CTRU) Seed Grant Funding Announcement -Due August 21

The CTRU announces an opportunity for FY18 funding (up to $40,000) to support pilot studies based in the University of Georgia CTRU.


ACTSI-supported Models Contribute to the First Possible Drug Treatment for Lymphedema

A recent study led by scientists at the Stanford University School of Medicine uncovered for the first time the molecular mechanism responsible for triggering lymphedema, as well as a drug with the potential for inhibiting that process....